Close

Pernix Therapeutics (PTX) Reports Q4 Net Loss of $81.7M

March 28, 2017 5:27 PM EDT

Pernix Therapeutics (NASDAQ: PTX) reported Q4 EPS net loss of $86.1 million, as compared to a net loss of $81.7 million for the three months ended December 31, 2015. Revenue for the quarter came in at $30.1 million, versus $41.5 million reported last year.

“We continue to assess various alternatives in order to proactively address our liquidity and capital structure in a constructive manner, including strategic and refinancing alternatives, asset sales, and mergers and acquisitions.”

For earnings history and earnings-related data on Pernix Therapeutics (PTX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Earnings, Management Comments

Related Entities

Earnings